We will be back soon with the regular monthly letters column
FarmaKeios reading of the statute also ignores the rule that courts must ascribe 15 To the extent FDA shares that view, see FDA, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act at 5 (2018), its interpretation of Section 503A is entitled to no deference
This article does not diagnose, treat, cure, or prevent any disease
How PlexusDx Supports a More Personalized Approach At PlexusDx, we recognize that medication storage and longevity intersect with personalized treatment planning
Their targeted mechanisms support precise therapeutic intervention, improving disease management and overall treatment outcomes
Frequency changes across the cycle, not the dose size